What is Primary Biliary Cholangitis?

Primary Biliary Cholangitis (previously referred to as primary biliary cirrhosis) is a condition in which your bile ducts are slowly destroyed due to the body’s immune system mistakenly attacking healthy tissues. The bile ducts produce bile which aid in digestion, helping the body to get rid of toxins, so when the bile ducts become damaged, this function is hindered, and the liver tissue becomes scarred. Treatment of this disease focuses on slowing liver damage and limiting complications.

Primary Biliary Cholangitis Clinical Trials

We have many different research studies of Primary Biliary Cholangitis of patients with known diagnoses of Primary Biliary Cholangitis who have not found their current treatment to be effective, or are willing to contribute to research. Patients who qualify for our Primary Biliary Cholangitis clinical trials may receive compensation for their time, see a board-certified physician at no cost to them, and have access to possible investigational medications.

What is the purpose of a clinical trial?

The purpose of conducting clinical trials for Primary Biliary Cholangitis is to determine the most effective and safe treatment options, and how those might apply differently to different individuals. Clinical trials are the  method of translating research into new medicines and treatments that can provide new and improved patient outcomes. The lengthiest step in conducting clinical trials is often finding participants for the trials. The outcomes of clinical trials are one of the vital considerations of the U.S. Food and Drug Administration’s drug approval process. Without FDA approval, there could be no advances in patient therapeutics.

How Do I Get Involved?

If you have Primary Biliary Cholangitis and want to get involved in a clinical trial for Primary Biliary Cholangitis, you should fill out the form at the top of this page, and you may be matched to a clinical trial that is right for you.